Plus therapeutics, inc. announces pricing of $15 million underwritten public offering

Austin, texas, sept. 23, 2019 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”) today announced the pricing of an underwritten public offering (the “offering”) of 3,000,000 units, each unit consisting of one share of common stock (or a common stock equivalent) and one series u warrant to purchase one share of common stock at a public offering price of $5.00 per unit. the shares of common stock (or common stock equivalents) and warrants comprising the units are immediately separable and will be issued separately, but will be purchased together. the series u warrants have an exercise price of $5.00 per share, are immediately exercisable and will expire five years from the date of issuance. the company has granted the underwriter a 45-day option to purchase up to an additional 450,000 shares of common stock and/or series u warrants to purchase up to 450,000 shares of common stock.
pstv Ratings Summary
pstv Quant Ranking